- €16.65m
- €38.86m
- €43.13m
- 36
- 73
- 46
- 49
Annual income statement for Bio-UV SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | FAS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 20 | 32.2 | 33.5 | 51.3 | 43.1 |
Cost of Revenue | |||||
Gross Profit | 6.43 | 10.2 | 11.9 | 16.8 | 15.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20.5 | 31.2 | 32.7 | 47.4 | 41.8 |
Operating Profit | -0.558 | 1.02 | 0.751 | 3.87 | 1.36 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.777 | 0.554 | 0.631 | 3 | 0.016 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.448 | 0.584 | 0.689 | 2.42 | 0.125 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.448 | 0.584 | 0.689 | 2.42 | 0.125 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.448 | 0.584 | 0.689 | 2.42 | 0.125 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.04 | 0.099 | 0.073 | 0.265 | 0.072 |
Dividends per Share | |||||
Special Dividends per Share |